The Traderszone Network

Published in TZ Latest News 7 December, 2015 by The TZ Newswire Staff

Strongbridge Biopharma Announces Issuance of U.S. Patent for Investigational COR-003 (levoketoconazole) in Treatment of Endogenous Cushing’s Syndrome